NGL Fine-Chem Limited Stock: price and insider trades · India
NGL Fine-Chem Limited: what insiders have been doing
NGL Fine-Chem Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). Over the twelve months to 31 October 2026, 8 filings were filed, from 1 insider.
The flow runs one way only: 8 sales worth €334k, from 1 insider, and no purchase. At €151k, the sale published on 8 June 2026 by Sunita Potdar is the largest of the period.
Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Across the 1,901 companies tracked on its exchange, the median is 4 filings; at 8 filings, this issuer sits above that mark. Looking back to 2023, when coverage begins, insiders filed no purchases and 24 sales.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 1,069 shares@ ₹2,828.800.017% mcap8.4% of flowEquity SharesMarket SaleSEBI:322580d21304f5efd584b653f1d04d495b29d524
- 368 shares@ ₹2,755.400.0055% mcap2.8% of flowEquity SharesMarket SaleSEBI:a85b244d9270057f224a82fd2d38dea051b68daf
- 1,281 shares@ ₹2,848.600.020% mcap10.0% of flowEquity SharesMarket SaleSEBI:3607a23728f8dadd9d349c14a30e5b3208684cfa
- 282 shares@ ₹2,715.600.0042% mcap2.1% of flowEquity SharesMarket SaleSEBI:478f603014a16b0a9bba708aae3a0b3dfd06acef
- 1,190 shares@ ₹2,838.100.018% mcap9.2% of flowEquity SharesMarket SaleSEBI:77e416ad0067e43ba7bc797611c6bd6c679256e3
- 1,364 shares@ ₹2,653.500.020% mcap9.9% of flowEquity SharesMarket SaleSEBI:9fcb211f5ce9cf7f883e392ec11c05ca16aac19a
- 6,424 shares@ ₹2,603.2045.4% of flowEquity SharesMarket SaleSEBI:7361bc4eaa8cba4a4bd7e9fba530c125793015a8
- 1,722 shares@ ₹2,674.5012.4% of flowEquity SharesMarket SaleSEBI:44a9c1b6dfe661c06c11ff827b52bb95ab6e9502
- 636 shares@ ₹2,008.39151.5% of flowEquity SharesSEBI:9bd62ac99273291f8ef455ca480761591c7a4149
- 474 shares@ ₹2,008.39031.1% of flowEquity SharesSEBI:8be9f93d054fe7afb9ce60b7a98a0c26c260fd69
- 10 shares@ ₹1,998.400.0% of flowEquity SharesSEBI:d64e59b886d9fe56bd639ebb62b0325db6f02f6d
- 4,191 shares@ ₹1,998.74789.8% of flowEquity SharesSEBI:ff050cb3e4e3d8e1e4c07dfdc7603d230df9b798
- 4,823 shares@ ₹2,014.009111.4% of flowEquity SharesSEBI:6373ac43802014194ae33aeee7743416c1e367ce
- 1,256 shares@ ₹2,100.59873.1% of flowEquity SharesSEBI:a5eeb99bf5ac06c1c4b28aa44cc20e98722b043c
- 9,348 shares@ ₹2,122.290123.3% of flowEquity SharesSEBI:fd90f064252063b39d29f3582f8e3c793fe04710
- 8,600 shares@ ₹2,228.722222.4% of flowEquity SharesSEBI:0b6791fce127a2a756c20c69f6ab316ff67d779e
- 110 shares@ ₹1,251.90910.2% of flowEquity SharesSEBI:dc1771b86448369a818086e5b0ba847b64b87dbb
- 9,890 shares@ ₹1,286.104915.0% of flowEquity SharesSEBI:e86e458b5f4864f2e53d10fe40311bf99cd56815
- 1,438 shares@ ₹1,374.67042.4% of flowEquity SharesSEBI:72a0eda6a85f48248cadd5f26b838606ce1b4d43
- 1,492 shares@ ₹1,408.4412.5% of flowEquity SharesSEBI:921b3220c0f594e71283c15c1997d2335f171c89
- 232 shares@ ₹1,448.88360.4% of flowEquity SharesSEBI:b58fefc87bc3d4c17ff0167a44e18b5ac14608b7
- 189 shares@ ₹1,451.12170.3% of flowEquity SharesSEBI:63a22909a4218772e71b945bba6a1bce6516a038
- 3,358 shares@ ₹1,469.56195.8% of flowEquity SharesSEBI:8a0cf379c70058533a4eb51089d9c1675d546c1f
- 400 shares@ ₹1,504.950.7% of flowEquity SharesSEBI:c0a90408bcae108ae2e5d6da6d7e7253f2f85bec
24 of 24 declarations
About NGL Fine-Chem Limited
NGL Fine-Chem Limited is a company specializing in the manufacture of fine chemicals and pharmaceutical products. It operates in the XBOM market and focuses on innovation and product quality.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
